乌鸦传媒

Authors >

Leah Lawrence

Leah Lawrence is a freelance health writer and editor based in Delaware. She has contributed to trade, consumer, and medical association publications and websites focused on hematology/oncology, cardiology, primary care, endocrinology, and general health.

Latest from Leah Lawrence

An Asian woman sitting on a couch and embracing her daughter who is fighting cancer

<乌鸦传媒>Double Mastectomy Linked to Sexual, Body Image Issues in Young Women

Pre-op counseling or decision aids could help women make better informed decisions

An elderly woman receives chemotherapy

<乌鸦传媒>Older Age Should Not Rule Out Chemo in Breast Cancer Patients

Providers should consider patient priorities when discussing treatment

The packaging and vial of Opdivo nivolumab

<乌鸦传媒>Nivolumab-Based Tx Effective in Early, Unfavorable Hodgkin's

Interim results showed high CR rates and almost 100% PFS, OS at 12 months

A female patient receiving chemotherapy talks to a nurse

<乌鸦传媒>CRC: Upfront, Re-Introduction of FOLFOXIRI Most Effective, but at What Cost?

Modest survival improvement comes with side effects, toxicity even in healthiest patients

A vial of Xgeva over a microscope image of multiple myeloma

<乌鸦传媒>Denosumab Use in Myeloma Soars for No Obvious Reason

More expensive than competitor without being better, so why does it now have nearly half the market?

A male physician discusses treatment options with a female breast cancer patient

<乌鸦传媒>Clinical Challenges: Sequencing in Second-Line Therapy in HR-positive Breast Cancer

Optimal therapy still varies by individual patient

A photo of a dermatologist examining the skin of a patient.

<乌鸦传媒>Second Primary Melanoma Increases Risk for Death

Data a reminder of the importance of regular skin exams

A photo of a regional cancer center entrance.

<乌鸦传媒>Time to End PPS-Exempt Status for Certain Cancer Centers?

Post-op outcomes largely similar to NCI-designated cancer centers

ASCO over a photo of McCormick Place in Chicago.

<乌鸦传媒>Clinical Challenge: Low PD-L1 Expression in NSCLC

Role of single-agent pembrolizumab in low PD-L1 expression disease still in question

<乌鸦传媒>'Encouraging' Early Data with Keytruda in High-Risk Bladder Ca

Will responses in non-muscle-invasive, BCG-unresponsive disease prove durable?

4